Our kits take you from single cell or single nuclei suspensions through sequencing straight into biological insights.
Target 100s to 1000s of genes to analyze more samples with less sequencing.
Pair guide RNAs with single cell whole transcriptomes.
Transform single cell sequencing output into understandable results.
Parse Biosciences provides researchers with the ability to perform single cell sequencing with unprecedented scale and ease.
A Seattle-based company with the mission of accelerating progress in human health and scientific research.
Customer interviews, single cell sequencing tips and tricks, and the latest updates from Parse Biosciences.
A list of upcoming conferences and webinars we are attending.
The latest news stories and press releases from Parse Biosciences.
Explore our library of resources to learn more about Evercode technology and some applications from leading researchers.
Download publications and posters featuring the Evercode technology in single cell research.
Explore datasets covering various applications and sample types or access product details.
Upcoming & past webinars on Evercode technology and its applications.
Information and insight for the entire range of Parse Biosciences products.
MEDIA ADVISORY
CEO and co-founder Alex Rosenberg, Ph.D. joining panel discussion at November 17 event in New York
WHAT:Senior executives from Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, will participate in the Canaccord Genuity Medtech, Diagnostics and Digital Health & Services Forum. The one-day event will profile public and private companies across the medical technology, diagnostic and digital health & services sectors.
WHO:Parse Biosciences CEO and co-founder Alex Rosenberg, Ph.D. will participate on a panel titled, “Oh Me, Oh My, Multiomics: A Panel Discussion of Scientists and Executives Highlighting Spatial Biology, Single Cell Analysis, Proteomics and Morpholomics.”
Alex Rosenberg and Parse Biosciences CFO Britton Russell will be available for one-on-one meetings with institutional investors during the conference.
WHEN:Panel: Thursday, November 17, 1:00 – 1:55 pm
WHERE:The Westin New York Grand Central212 E 42nd St, New York, NY 10017
CONTACTS:Investors: Robert Uhl, ICR Westwicke: robert.uhl@westwicke.com | 619.228.5886
Media: Lisa Owen, Parse Biosciences: lisa@parsebiosciences.com | 206-851-6246
About Parse BiosciencesParse Biosciences is a leading provider of accessible and scalable single cell sequencing solutions with the mission of accelerating progress in human health and scientific research. The company’s pioneering approach for single cell sequencing has already enabled groundbreaking discoveries which have led to new understandings of cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system. The company’s commercially available instrument-free products provide researchers with the ability to perform single cell sequencing at low cost with unprecedented scale and ease. Parse Biosciences is headquartered in Seattle.
To learn more about Parse Biosciences, please visit: https://www.parsebiosciences.com and follow us on Twitter and LinkedIn.